3020SP |
Methylphenidate and Metabolite, Serum/Plasma |
3042SP |
Metolazone, Serum/Plasma |
3043SP |
Metoprolol, Serum/Plasma |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3050SP |
Metronidazole, Serum/Plasma |
3057SP |
Midazolam, Serum/Plasma |
3061SP |
Milnacipran/Levomilnacipran, Serum/Plasma |
3063SP |
Mycophenolic Acid and Metabolite, Serum/Plasma |
3064SP |
Mitragynine, Serum/Plasma |
3082SP |
Molindone, Serum/Plasma |
3085SP |
Morphine and Glucuronide Metabolites, Serum/Plasma |
3103SP |
Nadolol, Serum/Plasma |
3107SP |
Nabumetone as Metabolite, Serum/Plasma |
3110SP |
Nalbuphine - Free (Unconjugated), Serum/Plasma |
3111SP |
Naloxone - Free (Unconjugated), Serum/Plasma |
3116SP |
Naltrexone and Metabolite - Free (Unconjugated), Serum/Plasma |
3118SP |
Nateglinide, Serum/Plasma |
3124SP |
1-Naphthol, Serum/Plasma |
3130SP |
Naproxen, Serum/Plasma |
3145SP |
Nefazodone, Serum/Plasma |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3158SP |
Nifedipine, Serum/Plasma |
3168SP |
Nitazenes Panel, Serum/Plasma |
3175SP |
Nitrazepam and Metabolite, Serum/Plasma |
3216SP |
Nordiazepam and Metabolite, Serum/Plasma |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3223SP |
Nonsteroidal Anti-Inflammatory Drug Panel, Serum/Plasma |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3225SP |
Nuedexta®, Serum/Plasma |
3226SP |
Olanzapine and Metabolite, Serum/Plasma |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3250SP |
Oxalate, Serum/Plasma |
3260SP |
Oxazepam, Serum/Plasma |
3265SP |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Serum/Plasma |
3266SP |
Oxybutynin and Metabolite, Serum/Plasma |
3270SP |
Oxycodone - Free (Unconjugated), Serum/Plasma |
3286SP |
Oxaprozin, Serum/Plasma |
3325SP |
Paraquat, Serum/Plasma |
3360SP |
Paroxetine, Serum/Plasma |
3381SP |
Penciclovir, Serum/Plasma |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3433SP |
Perampanel, Serum/Plasma |
3436SP |
Percodan®, Serum/Plasma |
3440SP |
Perphenazine, Serum/Plasma |
3580SP |
Phenobarbital, Serum/Plasma |
3581SP |
Phenobarbital - Unbound, Serum/Plasma |
3582SP |
Phenobarbital - Total/Unbound/Bound, Serum/Plasma |
3690SP |
Phentermine, Serum/Plasma |
3704SP |
Phenylephrine, Serum/Plasma |
3707SP |
Phenylethylmalonamide, Serum/Plasma |
3720SP |
Phenylpropanolamine, Serum/Plasma |
3743SP |
Phenytoin, Serum/Plasma |
3776SP |
Pimozide, Serum/Plasma |
3779SP |
Pioglitazone, Serum/Plasma |
3781SP |
Piroxicam, Serum/Plasma |
3788SP |
Prazosin, Serum/Plasma |
3790SP |
Posaconazole, Serum/Plasma |
3795SP |
Pregabalin, Serum/Plasma |
3900SP |
Primidone, Phenobarbital and PEMA, Serum/Plasma |
3901SP |
Primidone, Serum/Plasma |
3950SP |
Prochlorperazine, Serum/Plasma |
3970SP |
Promethazine, Serum/Plasma |